Table 5 Distribution of VAV3 rs7528153 genotypes among patients with or without altered basal glycaemia.
From: Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors
SNP | Genotype | Altered basal glycaemia | P value | OR (95% CI) | |||
|---|---|---|---|---|---|---|---|
Yes | No | ||||||
N | % | N | % | ||||
VAV3 rs7528153 | AA | 24 | 49.0 | 167 | 49.1 | Ref. | 1.000 |
AT | 15 | 30.6 | 141 | 41.5 | 0.362 | 0.727 (0.367–1.442) | |
TT | 10 | 20.4 | 32 | 9.4 | 0.068 | 2.169 (0.944–4.985) | |
VAV3 rs7528153 dominant | AA | 24 | 49.0 | 167 | 49.1 | Ref. | 1.000 |
AT + TT | 25 | 51.0 | 173 | 50.9 | 0.977 | 0.991 (0.543–1.807) | |
VAV3 rs7528153 recessive | AA + AT | 39 | 79.6 | 308 | 90.6 | Ref. | 1.000 |
TT | 10 | 20.4 | 32 | 9.4 | 0.024 | 2.481 (1.129–5.453) | |
